{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T15:47:37Z","timestamp":1770133657088,"version":"3.49.0"},"reference-count":37,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2008,8,19]],"date-time":"2008-08-19T00:00:00Z","timestamp":1219104000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Medical Virology"],"published-print":{"date-parts":[[2008,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Addition of in vivo alemtuzumab to the conditioning regimen enabled 2\u2010 or 3\u2010locus\u2010mismatched hematopoietic stem cell transplantation with an acceptable incidence of graft\u2010versus\u2010host\u2010disease. However, the procedure was associated with a high incidence of cytomegalovirus (CMV) reactivation. Although preemptive therapy with ganciclovir prevented successfully severe CMV diseases and CMV\u2010related mortality, a patient developed persistent positive CMV antigenemia for more than 1 year after transplantation and CMV disease, despite the use of ganciclovir and foscarnet. The in vitro susceptibility assay showed that the clinical isolate was resistant to foscarnet, moderately resistant to ganciclovir, but sensitive to cidofovir. Therefore, cidofovir was administered. CMV antigenemia became negative within 2 weeks and never developed again. Nucleotide sequence of the UL54 and UL97 of the clinical isolate showed 4 amino acid substitutions (V11L, Q578H, S655L, and G874R) in UL54 and 2 mutations (A140V and A594V) in UL97 compared with the Towne and AD169 strains. Ganciclovir resistance was suspected to be caused by both A594V of UL97 and Q578H of UL54, whereas foscarnet resistance was due mainly to Q578H of UL54. In conclusion, the in vitro susceptibility assay as well as nucleotide sequence of clinical isolate is important to choose appropriate antiviral agents for patients who have persistent CMV reactivation after stem cell transplantation. J. Med. Virol. 80:1769\u20131775, 2008. \u00a9 2008 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jmv.21277","type":"journal-article","created":{"date-parts":[[2008,8,21]],"date-time":"2008-08-21T15:32:09Z","timestamp":1219332729000},"page":"1769-1775","source":"Crossref","is-referenced-by-count":20,"title":["Case Report: Persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes"],"prefix":"10.1002","volume":"80","author":[{"given":"Kumi","family":"Oshima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinobu","family":"Kanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Kako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Asano\u2010Mori1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Motokura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeru","family":"Chiba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimiyasu","family":"Shiraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mineo","family":"Kurokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,8,21]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(99)00031-1"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705134"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-08-2398"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.10.4063.bloodjournal88104063"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.3.1071"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1399-3062.1999.010204.x"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.3.576"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1128\/jvi.62.1.188-195.1988","article-title":"A human cytomegalovirus function inhibits replication of herpes simplex virus","volume":"62","author":"Cockley KD","year":"1988","journal-title":"J Virol"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1386-6532(03)00163-X"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1182\/blood.V96.9.3286","article-title":"Drug\u2010resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes","volume":"96","author":"Eckle T","year":"2000","journal-title":"Blood"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703666"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2003.08.010"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.12.2.286"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1086\/516446"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.12.3669-3671.2001"},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1182\/blood.V82.3.807.807","article-title":"Effect of Campath\u20101H antibody on human hematopoietic progenitors in vitro","volume":"82","author":"Gilleece MH","year":"1993","journal-title":"Blood"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.49.4.1580-1583.2005"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0166-3542(98)00057-6"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.11.3676"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1702805"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-200202270-00015"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000158718.49286.14"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.7.2419"},{"key":"e_1_2_1_25_1","first-page":"1248","article-title":"Cytomegalovirus reactivation during alemtuzumab therapy for chronic lymphocytic leukemia: Incidence and treatment with oral ganciclovir","volume":"89","author":"Laurenti L","year":"2004","journal-title":"Haematologica"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1704505"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.45.10.2775-2780.2001"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2006.01413.x"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2002.n.016"},{"key":"e_1_2_1_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V97.4.867"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20150"},{"key":"e_1_2_1_32_1","first-page":"1682","article-title":"Effects of cyclosporine, azathioprine, mizoribine, and prednisolone on replication of human cytomegalovirus","volume":"22","author":"Shiraki K","year":"1990","journal-title":"Transplant Proc"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.7164\/antibiotics.44.550"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01310762"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1086\/514041"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-07-1982"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.20284"},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/0166-3542(95)00978-7"}],"container-title":["Journal of Medical Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjmv.21277","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jmv.21277","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T21:17:59Z","timestamp":1699996679000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jmv.21277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,21]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["10.1002\/jmv.21277"],"URL":"https:\/\/doi.org\/10.1002\/jmv.21277","archive":["Portico"],"relation":{},"ISSN":["0146-6615","1096-9071"],"issn-type":[{"value":"0146-6615","type":"print"},{"value":"1096-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,21]]}}}